2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
[HTML][HTML] 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
Direct oral anticoagulant use: a practical guide to common clinical challenges
A Chen, E Stecker, B A. Warden - Journal of the American Heart …, 2020 - Am Heart Assoc
Direct oral anticoagulants (DOAC s) have quickly become attractive alternatives to the long‐
standing standard of care in anticoagulation, vitamin K antagonist. DOAC s are indicated for …
standing standard of care in anticoagulation, vitamin K antagonist. DOAC s are indicated for …
[HTML][HTML] Cardiovascular research using the Korean national health information database
EK Choi - Korean circulation journal, 2020 - ncbi.nlm.nih.gov
Abstract The Korean National Health Information Database (NHID) contains nationwide
claims data, including sociodemographic data, health care utilization, health screening data …
claims data, including sociodemographic data, health care utilization, health screening data …
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
Direct oral anticoagulants in patients with atrial fibrillation and liver disease
Background: Advanced liver disease is known to increase the risk for bleeding and affects
the hepatic clearance and metabolism of drugs. Subjects with active liver disease were …
the hepatic clearance and metabolism of drugs. Subjects with active liver disease were …
Efficacy and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation across BMI categories: a systematic review and meta-analysis
Objectives Concerns have arisen recently over the relationship between body mass index
(BMI) and outcomes in atrial fibrillation (AF) patients with direct oral anticoagulants (DOACs) …
(BMI) and outcomes in atrial fibrillation (AF) patients with direct oral anticoagulants (DOACs) …
Oral anticoagulants beyond warfarin
RH Olie, K Winckers, B Rocca… - Annual review of …, 2024 - annualreviews.org
Direct oral anticoagulants (DOACs) have largely replaced vitamin K antagonists, mostly
warfarin, for the main indications for oral anticoagulation, prevention and treatment of …
warfarin, for the main indications for oral anticoagulation, prevention and treatment of …
[HTML][HTML] Safety and efficacy of DOACs in patients with advanced and end-stage renal disease
The prevalence of chronic kidney disease (CKD) is increasing due to the aging of the
population and multiplication of risk factors, such as hypertension, arteriosclerosis and …
population and multiplication of risk factors, such as hypertension, arteriosclerosis and …
Risk factors associated with ischemic stroke in Japanese patients with nonvalvular atrial fibrillation
K Okumura, H Tomita, M Nakai, E Kodani… - JAMA network …, 2020 - jamanetwork.com
Importance Despite the development of risk stratification schemes that have been widely
used to determine the risk for thromboembolism in patients with nonvalvular atrial fibrillation …
used to determine the risk for thromboembolism in patients with nonvalvular atrial fibrillation …